1.Determination of Plasma Concentration of Harmine Derivative DH- 330 by UPLC-MS and Its Pharmacokinetics Ev aluation in Rats
Huijing GAO ; Ahmat ARSLAN ; Zhaohui XU ; Wenxi FAN ; Guoru CHEN ; Jun ZHAO
China Pharmacy 2019;30(12):1590-1594
OBJECTIVE: To establish a method for the determination of harmine derivative DH-330 in rat plasma and to use it for pharmacokinetic behavior evaluation of DH-330 in rats after intragastric administration. METHODS: Using tinidazole as internal standard, after pre-treatment of acetonitrile precipitated protein, UPLC-MS method was adopted to determine the plasma concentration of DH-330. UPLC analysis was performed on Waters ACQUITY BEH C18 column (50 mm×2.1 mm,1.7 μm) with mobile phase consisted of acetonitrile-methanol-0.5% formic acid aqueous solution(15 ∶ 55 ∶ 30, V/V/V) at flow rate of 0.4 mL/min, while the column temperature was 30 ℃, and sample size was 5 μL. MS analysis was conducted by electrospray ionization source, positive ion scanning, ion source temperature at 124 ℃, DH-330 detection of mass to charge ratio (m/z) of 335.8→334.8, and internal standard m/z of 247.0→81.0. Six Wistar rats were given DH-330 suspension(50 mg/kg) intragastrically. Blood samples were collected from fundus venous plexus capillary before administration (0 h) and 0.25,0.5,1,2,4,6,8,12,24 h after administration. Plasma concentration of DH-330 was determined and plasma concentration-time curves were drawn. Pharmacokinetic parameters were calculated by using Kinetica 5.0 software. RESULTS: The linear ranges of DH-330 were 25.05-2 004 ng/mL(r=0.999 8),and the limits of quantitation was 25.05 ng/mL. RSDs of intra-day and inter-day were all less than 10%. The accuracy RE was -9.76% to 4.55%. The extraction recovery was higher than 85%(RSD<5%). Stability RE was -2.53% to 2.29%. They were not affected by matrix effect or residual effect of injection. The pharmacokinetic parameters of DH-330 in rats after intragastric administration included that cmax was (1 162.43±241.72)ng/mL,AUC0-∞ was (3 242.93±652.31)ng·h/mL,t1/2 was (1.93±0.61)h, MRT was (3.23±0.30)h,CL was (16.80±5.30)L/h·kg, Vss was (54.78±19.64)L/kg. CONCLUSIONS: The established method is simple, specific, sensitive, precise and recovery, which can be used for the plasma concentration determination of DH-330 in rats. DH-330 has short half-life, rapid absorption and large apparent distribution volume after intragastric administration in rats, which indicates that it has high lipophilicity and may be mainly distributed in tissues.